FACTOR II AND FIBRINOGEN FOR TREATMENT OF HAEMOSTATIC DISORDERS

• 收藏
• 分享

专利权人:

MEDIMMUNE LIMITED

发明人:

LOVGREN, ANN,HANSSON, KENNY

申请号：

SG2013021498

公开号：

SG188639A1

申请日:

2011.09.19

申请国别(地区):

SG

年份:

2013

代理人:

摘要：

The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII (2) PCC and (3) a three factor combination of FII, FX, and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/